Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07144137 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Study acronym: Pre-GAIN
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 17 to 18
    • Eligibility criteria expanded, about 30 words
  2. Trial sites expanded: 14 → 17 locationsv10
  3. Site details revised at 2 of 14 sitesv9
  4. Study sites: 13 to 14v8
  5. Study sites: 12 to 13v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 11 to 12v6
  2. Study sites: 9 to 11v5
  3. Study sites: 7 to 9v4
  4. Study sites: 1 to 7v3
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a non-interventional, observational study to provide insights into the short-term progression of GA secondary to AMD in participants aged ≥55 years. This is a multi-center, non-interventional, observational study which aims to identify participants who have progressive GA to allow quantification of structural and functional parameters that characterize the progression of GA, and to investigate whether these correlate with genetic or lifestyle factors.
Trial Details
NCT Number NCT07144137
Lead Sponsor Complement Therapeutics
Conditions
(from sponsor)		 Geographic Atrophy Secondary to Age-related Macular Degeneration
Related terms Geographic Atrophy, Macular Degeneration
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov